Ultime notizie per  (OTC:VGRRF) Azioni

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2026 sales outlook from $1.52 billion-$1.77 billion to $1.52 billion-$1.77 billion vs $1.70 billion estimate.

News

Guidance

VTOL

Bristow Group Affirms FY2026 Sales Guidance of $1.52B-$1.77B vs $1.70B Est

System1 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.32) by 34.38 percent. This is a 53.33 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $74.51 million which beat the analyst consensus estimate of $69.87 million by 6.64 percent. This is a 12.25 percent decrease over sales of $84.92 million the same period last year.

Earnings

Earnings Beats

System1 Q1 EPS $(0.21) Beats $(0.32) Estimate, Sales $74.51M Beat $69.87M Estimate

WIIM

Gen Digital shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 and Q1 guidance above estimates.

Earnings Misses

American Finl Gr Q1 Adj. EPS $1.81 Misses $2.03 Estimate, Sales $1.58B Miss $1.74B Estimate

PSX Leadership Supports Poor Performance and the Status Quo&nbsp;
Elliott's "Streamline 66" Plan Would Create a Stronger Phillips 66 Based on Experience and Results, Not Rhetoric&nbsp;
Visit <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4421548-1&amp;h=103704435&amp;u=https%3A%2F%2Fstreamline66.com%2Fpresentations%2F&amp;a=Streamline66.com">Streamline66.com</a> to Download the Full Presentation
WEST PALM BEACH, Fla., May 6, 2025 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together make it a top-five shareholder in Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) (the "Company" or "Phillips"), today released an investor presentation titled "Streamline 66: The Choice for Shareholders."
Elliott presented Phillips 66 shareholders with a simple choice ahead of the Annual General Meeting on May 21st. Do shareholders want to support the current leadership team, which considers its performance acceptable and is committed to the status quo? Or do shareholders want to elect shareholder-nominated directors empowered to drive accountability and improve long-term performance?

Management

Elliott Management Presents The Choice For Phillips 66 Shareholders; Says "Streamline 66" Plan Would Create A Stronger Phillips 66 Based On Experience And Results, Not Rhetoric

ANET

Arista Networks shares are trading lower after the company reported a Q1 sales miss.

Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) reported first-quarter financial results Tuesday after the market close. Here&#8217;s a look at the key details <a href="https://www.benzinga.com/pressreleases/25/05/b45234780/tempus-reports-first-quarter-2025-results">from the report</a>.
Q1 Earnings: Tempus AI reported first-quarter revenue of $255.74 million, beating&nbsp;<a href="https://www.benzinga.com/quote/TEM/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $248.13 million. The AI-focused precision medicine and patient care company reported a first-quarter adjusted loss of 24 cents&nbsp;per share, beating analyst estimates for a loss of 27 cents&nbsp;per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Total revenue was up 75.4% year-over-year as genomics revenue grew 88.9% year-over-year to $193.8 million. Data and services revenue grew 43.2% to $61.9 million, led by Insights (data licensing), which grew&nbsp;58%&nbsp;year-over-year.
Tempus AI highlighted multi-year strategic collaborations with AstraZeneca and Pathos, resulting in an additional $200 million in data licensing and model development fees over the next three years. The company had approximately $151.6 million in cash and equivalents at the quarter's end.
&#8220;The business is performing well with revenues growing, margins improving, and our costs remaining in check, allowing us to demonstrate significant year-over-year operating leverage,&#8221; said&nbsp;Eric Lefkofsky, founder and CEO of Tempus AI.
&#8220;Our strategic investments in AI have us uniquely positioned to advance what is possible in diagnostics and drug development, as evidenced by our announcement to build the largest foundation model in oncology with AstraZeneca and Pathos. We believe this is just the beginning as more and more healthcare providers and life science companies embrace AI.&#8221;
Outlook: Tempus AI raised its full-year 2025 revenue guidance from $1.24 billion to $1.25 billion for its consolidated Tempus and Ambry Genetics business, which represents approximately 80% annual growth.
The company continues to expect full-year 2025 adjusted EBITDA of $5 million, versus a full-year adjusted EBITDA loss of $104.7 million in full-year 2024.
Tempus AI executives will further discuss the company&#8217;s quarterly results on a conference call set for 4:30 p.m. ET
TEM Price Action: <a href="http://benzinga.com/quote/ai" target="_blank" rel="noreferrer noopener">Tempus AI shares</a> were up 5.79% after hours, trading at $55.21 at the time of publication on Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/04/44976660/beyond-the-numbers-9-analysts-discuss-tempus-ai-stock">Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock</a></li>
</ul>
Photo: Piotr Swat/Shutterstock.

Health Care

Movers

Tempus AI Q1 Earnings: Revenue Beat, EPS Beat, Raised FY Guidance, Shares Surge

Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) is looking for Q2 Adj EPS of $5.05-$5.15 vs $5.13 analyst estimate..

CPAY

Corpay Sees Q2 Adj EPS $5.05-$5.15 vs $5.13 Est

Forrester Res (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORR#NASDAQ">FORR</a>) lowers FY2025 GAAP EPS guidance from $0.24-$0.34 to $(4.23)-$(4.08) vs $0.30 analyst estimate..

FORR

Forrester Res Lowers FY2025 GAAP EPS Guidance from $0.24-$0.34 to $(4.23)-$(4.08) vs $0.30 Est

<h3>Gainers</h3>
<ul>
<li>Netclass Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares rose 73.7% to $57.32 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. </li>
<li>Purple Innovation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPL#NASDAQ">PRPL</a>) shares increased by 20.22% to $0.89. The company's market cap stands at $96.8 million. As per the news, the Q1 earnings report came out today. </li>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGA#NASDAQ">QVCGA</a>) stock moved upwards by 13.95% to $0.27. The company's market cap stands at $110.3 million. </li>
<li>Wah Fu Education Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFU#NASDAQ">WAFU</a>) shares rose 13.15% to $1.57. The company's market cap stands at $6.9 million. </li>
<li>Aureus Greenway Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) stock rose 12.03% to $0.69. The market value of their outstanding shares is at $9.6 million. </li>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock moved upwards by 9.76% to $6.97. The company's market cap stands at $7.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WW International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) stock declined by 39.7% to $0.48 during Tuesday's after-market session. The market value of their outstanding shares is at $38.2 million. As per the news, the Q1 earnings report came out today. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) stock decreased by 27.23% to $2.54. The company's market cap stands at $2.9 million. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) shares declined by 15.3% to $0.28. The market value of their outstanding shares is at $40.8 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares fell 10.7% to $0.47. The market value of their outstanding shares is at $135.4 million. </li>
<li>Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) stock decreased by 10.62% to $16.93. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out today. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) stock decreased by 6.05% to $11.51. The company's market cap stands at $78.7 million. The company's, FY earnings came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LXEH

MKDW

MTEN

NTCL

NWTN

PRPL

QVCGA

RVLV

VMAR

WAFU

12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

System1 shares are trading higher following a Q1 sales beat.

<h3>Gainers</h3>
<ul>
<li>Lipocine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPCN#NASDAQ">LPCN</a>) shares rose 15.1% to $3.66 during Tuesday's after-market session. The company's market cap stands at $19.5 million. </li>
<li>Cumberland (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) shares increased by 11.11% to $4.9. The market value of their outstanding shares is at $68.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) shares moved upwards by 10.89% to $20.25. The market value of their outstanding shares is at $356.7 million. The company's, Q1 earnings came out today. </li>
<li>Harvard Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBIO#NASDAQ">HBIO</a>) stock moved upwards by 10.0% to $0.33. The company's market cap stands at $14.5 million. </li>
<li>OneMedNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) shares moved upwards by 9.84% to $0.42. The company's market cap stands at $11.8 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) shares rose 9.35% to $0.49. The market value of their outstanding shares is at $71.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) stock fell 20.7% to $37.0 during Tuesday's after-market session. The company's market cap stands at $3.6 billion. The company's, Q1 earnings came out today. </li>
<li>Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) stock decreased by 18.44% to $5.93. The company's market cap stands at $546.5 million. As per the news, the Q1 earnings report came out today. </li>
<li>AquaBounty Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQB#NASDAQ">AQB</a>) shares decreased by 16.87% to $0.78. The market value of their outstanding shares is at $3.0 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) stock fell 8.82% to $3.0. The company's market cap stands at $4.4 million. </li>
<li>Tharimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THAR#NASDAQ">THAR</a>) stock fell 8.49% to $1.51. The market value of their outstanding shares is at $2.9 million. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares fell 8.48% to $1.08. The company's market cap stands at $4.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATNF

BDSX

CPIX

EVOK

HBIO

LPCN

MYGN

ONMD

RIGL

SRPT

THAR

12 Health Care Stocks Moving In Tuesday's After-Market Session

Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) is looking for Q2 GAAP EPS of $3.82-$3.92 vs $4.11 analyst estimate..

Corpay Sees Q2 GAAP EPS $3.82-$3.92 vs $4.11 Est

Ashford Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHT#NYSE">AHT</a>) reported quarterly losses of $(0.98) per share which missed the analyst consensus estimate of $5.86 by 116.72 percent. This is a 72 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $277.36 million which missed the analyst consensus estimate of $319.00 million by 13.05 percent. This is a 8.73 percent decrease over sales of $303.90 million the same period last year.

Ashford Hospitality Trust Q1 FFO $(0.98) Misses $5.86 Estimate, Sales $277.36M Miss $319.00M Estimate

Opendoor Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) released its first-quarter results after Tuesday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/25/05/g45235127/opendoor-announces-first-quarter-of-2025-financial-results">from the report.</a>
The Details: Opendoor Technologies reported quarterly losses of nine cents per share, which beat the analyst consensus estimate of losses of 10 cents. Quarterly revenue of $1.15 billion beat the analyst consensus estimate of $1.06 billion.
Read Next:&nbsp; <a href="https://www.benzinga.com/news/legal/25/05/45226604/president-trump-wants-to-reopen-alcatraz-heres-what-it-would-take?utm_source=articleShare">President Trump Wants To Reopen Alcatraz: Here&#8217;s What It Would Take</a>
For the first quarter, Opendoor reported:
<ul>
<li>Inventory balance of $2.4&nbsp;billion, representing 7,080 homes, up 26% year-over-year.</li>
<li>Purchased 3,609 homes, up 4% year-over-year. </li>
<li>Ended the quarter with 1,051 homes under contract for purchase, down 60% from the prior year&#8217;s quarter. </li>
</ul>
&#8220;We&#8217;ve spent the last decade building a modern real estate platform — designed to deliver simplicity, certainty and a customer-first experience. We entered 2025 with a clear plan to drive toward profitability while strengthening our product experience and platform. Our first-quarter results reflect disciplined execution: we improved Adjusted EBITDA and sharply reduced Adjusted Net Losses,&#8221; said Carrie Wheeler, CEO of Opendoor.
Outlook:&nbsp;Opendoor issued second-quarter&nbsp;revenue guidance of $1.45 billion to $1.525 billion. 
OPEN Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Opendoor stock was up 8.37% after-hours at 76 cents on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45228179/upwork-delivers-solid-start-to-2025-analyst?utm_source=articleShare">Upwork Delivers &#8216;Solid Start To 2025&#8217;: Analyst&nbsp;</a></li>
</ul>
Image: Shutterstock

Penny Stocks

Markets

Tech

Real Estate

OPEN

Opendoor Stock Rallies After Better-Than-Expected Q1: Details

<h3>Gainers</h3>
<ul>
<li>Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) stock rose 13.5% to $5.72 during Tuesday's after-market session. The company's market cap stands at $1.2 billion. The company's, Q1 earnings came out today. </li>
<li>Concorde Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) shares moved upwards by 12.38% to $4.9. The company's market cap stands at $108.4 million. </li>
<li>Energys Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGS#NASDAQ">ENGS</a>) stock increased by 6.87% to $2.8. The company's market cap stands at $39.9 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) shares increased by 6.12% to $0.31. The market value of their outstanding shares is at $44.3 million. </li>
<li>Astronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) stock moved upwards by 5.91% to $24.88. The company's market cap stands at $881.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) stock increased by 5.44% to $0.48. The market value of their outstanding shares is at $12.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock decreased by 51.6% to $0.18 during Tuesday's after-market session. The market value of their outstanding shares is at $5.4 million. </li>
<li>Vestis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) shares declined by 28.94% to $6.19. The market value of their outstanding shares is at $815.5 million. The company's, Q2 earnings came out today. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) stock fell 16.67% to $1.65. The company's market cap stands at $11.3 million. </li>
<li>Toppoint Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOPP#AMEX">TOPP</a>) stock declined by 10.38% to $1.21. The company's market cap stands at $21.1 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock declined by 9.76% to $0.45. The company's market cap stands at $35.7 million. </li>
<li>Lakeside Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) shares decreased by 5.91% to $0.92. The company's market cap stands at $6.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATRO

CIGL

ENGS

EOSE

LGCL

PGHL

SCWO

TOPP

VSTE

VSTS

12 Industrials Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Porch Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) shares rose 13.5% to $7.2 during Tuesday's after-market session. The market value of their outstanding shares is at $736.2 million. The company's, Q1 earnings came out today. </li>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) shares increased by 10.43% to $6.99. The company's market cap stands at $85.8 million. </li>
<li>Atomera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) shares increased by 10.25% to $5.59. The company's market cap stands at $171.6 million. As per the news, the Q1 earnings report came out today. </li>
<li>Sagtec Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGT#NASDAQ">SAGT</a>) shares increased by 8.93% to $5.85. The company's market cap stands at $73.4 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) shares increased by 8.45% to $1.54. The company's market cap stands at $9.4 million. </li>
<li>Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) stock rose 7.31% to $16.0. The market value of their outstanding shares is at $258.7 million. As per the press release, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock decreased by 32.3% to $1.09 during Tuesday's after-market session. The market value of their outstanding shares is at $3.9 million. </li>
<li>Kulicke &amp; Soffa Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>) shares fell 8.64% to $29.0. The company's market cap stands at $1.5 billion. The company's, Q2 earnings came out today. </li>
<li>Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) shares decreased by 8.11% to $0.68. The company's market cap stands at $40.8 million. </li>
<li>Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) stock fell 7.41% to $84.05. The market value of their outstanding shares is at $105.5 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) stock declined by 5.99% to $0.31. The market value of their outstanding shares is at $9.0 million. </li>
<li>Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) stock fell 5.92% to $57.6. The company's market cap stands at $49.8 billion. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATOM

AUID

FOXO

KLIC

MRVL

PRCH

SAGT

SGMA

12 Information Technology Stocks Moving In Tuesday's After-Market Session

Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) lowers FY2025 GAAP EPS guidance from $16.50-$17.00 to $16.37-$16.77 vs $16.85 analyst estimate..

Corpay Lowers FY2025 GAAP EPS Guidance from $16.50-$17.00 to $16.37-$16.77 vs $16.85 Est

XChange TEC.INC shares are trading lower after the company announced plans to change its ADS ratio from 1-to-120 to 1-to-2400.

Triple Flag Precious (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFPM#NYSE">TFPM</a>) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.19 by 5.26 percent. The company reported quarterly sales of $82.20 million which beat the analyst consensus estimate of $73.90 million by 11.23 percent.

TFPM

Triple Flag Precious Q1 EPS $0.20 Beats $0.19 Estimate, Sales $82.20M Beat $73.90M Estimate

Comments

Notizie

Ultime notizie per (OTC:VGRRF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO